For research purposes only
Semaglutide is a 31-amino acid peptide with structural modifications compared to native GLP-1. It has two key modifications: a substitution of alanine at position 8 with 2-aminoisobutyric acid (Aib) and the addition of a fatty diacid side chain to lysine at position 26.




Reviews
There are no reviews yet.